Search results
ARUP Files Declaration to Support Lawsuit Challenging the FDA's Rule to Regulate Lab-Developed Tests
The Herald Journal· 3 days agoARUP Laboratories is backing a federal lawsuit filed by the American Clinical Laboratory Association (ACLA) challenging the FDA's final rule to regulate ...
Prostate cancer: Protein identified to reduce tumor growth
Medical Xpress· 1 day agoAn international study led by Lukas Kenner and Sabine Lagger has now identified a protein that could slow tumor growth. The results, which have just been published in Molecular Cancer, provide ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days agoIn an era where healthcare innovation is paramount, KFSHRC Jeddah has made headway in the treatment of severe Xanthoma through the deployment of a modified plasma exchange protocol. The condition's ...
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer...
Nature· 6 days agoEthical approval to generate patient-derived models was obtained through the Tracking Cancer Evolution through Therapy (TRACERx) clinical study (REC reference: 13/LO/1546; ...
Navigate BioPharma Services, Inc. Launch Assay for Precise Measurement of Radioligand Therapy...
Benzinga· 6 days agoCARLSBAD, Calif., May 31, 2024 /PRNewswire/ -- Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and ...
Deployment and validation of the CLL treatment infection model adjoined to an EHR system - npj...
Nature· 1 day agoData harmonization was achieved through the development of mapping dictionaries, which aligned variable nomenclature and units with the specific requirements of CLL-TIM (See Fig. 2 and Methods ...
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI...
Benzinga· 7 days agoREDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting
Labs, Doctors Still Grapple With Patient Recontact Despite Streamlined Variant Reclassification
GenomeWeb News· 6 days agoAlmost four years after the ruling in favor of Quest Diagnostics in one of the most notable genetic...
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating...
Benzinga· 1 day agoOSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant At the American Transplant Congress 2024 (June 1-5 Philadelphia) Nantes,
EmeritusDX Continues Expansion, Announces New Director of Sales for Central U.S.
PRWeb· 3 days ago"We are thrilled to welcome Allison to the EmeritusDX family," said Robert Embree, CEO of EmeritusDX. "I am excited to announce my appointment as the new Director of Sales for the Central Region at EmeritusDX," said Allison Iredale.